US68232V8019 - Common Stock
Traws Pharma just reported results for the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Traws Pharma (NASDAQ:TRAW) just reported results for the second quarter of 2024...
Merger with Trawsfynydd Therapeutics, Inc (“Trawsfynydd”) and concurrent private placement of $14 million (cash runway to support planned operations...
NEWTOWN, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (“Traws” or “Traws Pharma”), a clinical stage biopharmaceutical company developing...
Differentiated resistance profile positions Traws’ program as a potential class leader
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update...